Last reviewed: June 21, 2026
Last updated: June 21, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide works by activating GLP-1 receptors in the brain to reduce appetite and slow stomach emptying, helping patients lose an average of 15-22% of body weight over 68 weeks according to clinical trials. Starting with the correct dose and following a structured titration plan is essential for both safety and effectiveness. This guide explains how semaglutide dosing works and how PlexusDx personalizes your treatment plan.
Understanding Semaglutide Dose Escalation Protocol
Semaglutide injections follow a four-week escalation schedule designed to help your body adapt to the medication while minimizing nausea and gastrointestinal side effects. Most patients begin at 0.25 mg once weekly, then increase by 0.25 mg increments every four weeks until reaching their therapeutic dose of 0.5-1.0 mg weekly. This gradual approach allows your system to adjust to the medication's effects on appetite and glucose regulation without overwhelming your digestive system.
The standard titration ladder takes approximately 16-20 weeks to reach maintenance dosing, though some patients may need a slower progression based on their individual tolerance. PlexusDx medical providers review your tolerance at each stage and can adjust the timeline if needed. Your dose may need to go up. Your price won't—PlexusDx maintains flat monthly pricing regardless of which dose level you're on, ensuring transparent and predictable healthcare costs.
How to Inject Your Semaglutide Dose Correctly
Semaglutide injections are administered subcutaneously (under the skin) once per week, typically in the abdomen, thigh, or upper arm. Before each injection, inspect the cartridge or pen for particles or discoloration—the solution should appear clear and colorless. Clean the injection site with an alcohol swab, pinch the skin gently, insert the needle at a 45-90 degree angle, and inject slowly over 3-5 seconds to minimize discomfort and bruising.
Rotate injection sites weekly to prevent lipohypertrophy (thickened skin tissue) and improve absorption consistency. Store your semaglutide in the refrigerator at 2-8°C before first use, then keep it at room temperature after opening. PlexusDx provides detailed video training and written instructions with each shipment, and medical staff are available to answer technique questions via phone or secure messaging.
Personalizing Your Dose Based on Body Composition and Genetics
Genetic variations in the GLP-1 receptor gene (GLP1R rs6923761) and other peptide pathways significantly influence how your body responds to semaglutide dosing. Some patients carry genetic variants that enhance GLP-1 signaling, allowing them to achieve results at lower doses, while others may require higher therapeutic doses to activate the same appetite-suppressing pathway. PlexusDx Precision Peptide Genetic Test analyzes 14 metabolic pathways and 49 peptide variants to predict your optimal starting dose and titration pace.
The FTO rs9939609 variant, associated with increased appetite drive, helps PlexusDx providers anticipate whether you'll benefit from a more aggressive or conservative dosing strategy. Patients with certain genetic predispositions may experience stronger side effects at standard doses, prompting a slower escalation or a switch to oral semaglutide formulations. Adding the Precision Peptide Genetic Test ($99 add-on after your first month) gives your PlexusDx provider molecular insights that transform your treatment from one-size-fits-all to truly personalized.
Managing Side Effects While Optimizing Your Dose
Nausea is the most common side effect during dose escalation, typically peaking 2-4 days after injection and subsiding by day 5-6 as your body adjusts. Eating small, frequent meals; avoiding fatty or overly sweet foods; and staying well-hydrated can significantly reduce nausea severity. If nausea persists or becomes intolerable, inform your PlexusDx provider—they may recommend staying at your current dose for an additional week before increasing, or switching to oral semaglutide, which often produces milder gastrointestinal effects.
Constipation occurs in approximately 20-30% of semaglutide users because the medication slows gastric emptying, allowing more time for water absorption in the colon. Increasing fiber intake gradually, drinking 80-100 ounces of water daily, and taking a stool softener like docusate sodium can prevent this side effect. PlexusDx provides side effect management guidance with every dose adjustment, and your provider can recommend whether to pause your escalation, modify your diet, or consider adding supportive medications temporarily.
Monitoring Weight Loss Progress and Adjusting Your Semaglutide Dose
Most patients begin noticing appetite suppression within 5-7 days of their first injection, with measurable weight loss typically appearing by week 4 of treatment. Weigh yourself weekly at the same time of day (preferably in the morning before eating) and track your measurements and how your clothes fit, as muscle gain can offset fat loss on the scale. Average weight loss accelerates as you reach your therapeutic maintenance dose, with patients losing approximately 1-2 pounds weekly during months 2-6 of consistent dosing.
If weight loss plateaus for more than 4 weeks despite consistent medication adherence and lifestyle changes, your PlexusDx provider may recommend increasing your dose further (up to 2.4 mg weekly), switching to dual-compound therapy like GLP-Squared Injection, or adding the Precision Peptide Genetic Test to identify previously unmapped genetic factors limiting your response. PlexusDx supports 50 states without insurance requirements, making ongoing adjustments and optimization completely accessible regardless of your coverage status.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the starting dose of semaglutide, and when should I increase it?
PlexusDx patients start semaglutide at 0.25 mg weekly and increase by 0.25 mg every four weeks, following a standard titration protocol. Your PlexusDx provider reviews your tolerance and side effects at each escalation point and can adjust timing if needed. Starting low and increasing gradually minimizes nausea while your body adapts to the medication.
How much weight can I expect to lose on semaglutide, and does dose matter?
Clinical trials show semaglutide produces 15-22% average body weight reduction over 68 weeks when combined with lifestyle changes. Higher maintenance doses (1.0-2.4 mg weekly) generally produce greater weight loss than lower doses, though genetics and individual metabolism significantly influence results. The Precision Peptide Genetic Test helps PlexusDx identify your genetic weight-loss potential at different dose levels.
How much does semaglutide cost at PlexusDx?
PlexusDx Compounded Semaglutide Injection starts at $149 per month and remains flat regardless of your dose level—whether you're at 0.25 mg or 2.4 mg weekly. No insurance is required, and the medication is HSA/FSA eligible. PlexusDx serves all 50 states with licensed 503A compounding pharmacy sourcing.
Are there serious side effects from semaglutide dosing I should know about?
Serious side effects are rare but include pancreatitis (severe abdominal pain), gallbladder complications, and thyroid changes in predisposed individuals. Nausea, constipation, and mild vomiting are common during titration and typically resolve as your body adjusts. PlexusDx providers screen for contraindications before starting and monitor for adverse effects at each dose adjustment through secure messaging and follow-up calls.
Can the Precision Peptide Genetic Test predict whether my dose needs to be higher or lower?
Yes—PlexusDx Precision Peptide Genetic Test analyzes GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313, along with 10 other key pathway variants. Certain genetic patterns indicate whether you'll respond robustly at standard doses or require higher titration for optimal appetite suppression. At $99 add-on after your first month, the test transforms your dosing strategy from guesswork to precision medicine.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Will Ozempic Help with Prediabetes?
Optimizing Ozempic® Storage and Injection: Can You Take It Cold?